We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
The current TCLIF market cap is 14.63M. The company's latest EPS is EUR -0.0804 and P/E is -3.11.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 3.22M | 1M | 1.71M | 1.37M | 3.92M |
| Operating Income | -4.5M | -4.05M | -4.51M | -6.28M | -2.59M |
| Net Income | -3.79M | -3.91M | -3.76M | -4.96M | -3.68M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 10.51M | 10.55M | 11.83M | 13.94M | 18.66M |
| Total Liabilities | 10.59M | 13.78M | 13.1M | 13.4M | 13.02M |
| Total Equity | -80k | -3.24M | -1.27M | 545k | 5.65M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -3.69M | -3.32M | -3.88M | -5.27M | -2.49M |
| Investing | -317k | -192k | -524k | -740k | -213k |
| Financing | 4.53M | 4.41M | 4.56M | 6.03M | 7.99M |
| Market Cap | 14.63M |
| Price to Earnings Ratio | -3.11 |
| Price to Sales Ratio | 2.92 |
| Price to Cash Ratio | 1.46 |
| Price to Book Ratio | 2.02 |
| Dividend Yield | - |
| Shares Outstanding | 45.73M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -45.76% |
| 52 Week High | 0.59 |
| 52 Week Low | 0.00017 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Theraclion (CE) |
| Address |
immeuble le vaillant ,244 avenue pierre brossolette malakoff, hauts-de-seine 92240 |
| Website | https://www.theraclion.com |
| Industry | med, dental, hosp eq-whsl (5047) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
